Despite limitations, therapeutic drug monitoring may be of value in antiretroviral treatment in HIV-infected patients

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.7, 2005-07, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Drug Monitoring in the Management of HIV-Infected Patients

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-08 ,pp. : 1925-1939

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Drug Monitoring: A Tool to Individualize Highly Active Antiretroviral Therapy in HIV Infected Patients

Current Pharmaceutical Analysis, Vol. 2, Iss. 3, 2006-08 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action

By Bazzoli Caroline Jullien Vincent > Rey Elisabeth Mentré France Taburet Anne-Marie

Clinical Pharmacokinetics, Vol. 49, Iss. 1, 2010-01 ,pp. : 17-45

Adis International

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen Morelló Judit Garcia-Gascó Pilar Rodríguez-Novoa Sonia Soriano Vincent

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

By Fisher Stacy D.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 383-394

Adis International

Access to resources Recommend Favorite